Malaria, Vivax: Clinical Trials

29 trials for Malaria, Vivax, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

17 completed, 6 not yet recruiting, 2 terminated, 2 unknown. 29 Phase 2, 6 Phase 1, 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 229Completed 17, Not yet recruiting 6, Terminated 2, Unknown 2, Withdrawn 2
Phase 16Completed 4, Not yet recruiting 1, Unknown 1
Phase 34Not yet recruiting 2, Completed 1, Withdrawn 1

Follow Malaria, Vivax: new trials by email Literature Review of Malaria, Vivax trials Research Report on Malaria, Vivax

Trials (filtered) newest first · largest first

All 29 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
This is a Clinical Study to Assess Whether the Combination of SJ733 and Tafenoquine Will be a Safe and Rapidly Acting Anti-malarial for the Radical Cure of P. Vivax Malaria
SJ733/TQ placebo, CQ/TQ Placebo, CQ/TQ - Malaria, Malaria Vivax
Phase 2Not yet recruitingR. Kiplin Guy1042026-12-012026-10-21
Transmission-Blocking Vaccine Pvs230D1-EPA/Matrix-M in Healthy Malaria-Naive Adults Using a Plasmodium Vivax Controlled Human Malaria Infection and Transmission Model
Plasmodium vivax Challenge Agent Derived from PvHMB-CCE001, Pvs230D1-EPA/Matrix-M - Healthy Volunteers, Malaria
Phase 1 / Phase 2Not yet recruitingNational Institute of Allergy and Infectious Diseases (NIAID)2202026-11-192026-11-16
Tafenoquine Drug Levels in Small Children
Chloroquine, Tafenoquine - Plasmodium Vivax Malaria, Vivax Malaria
Phase 2Not yet recruitingUniversity of Oxford202026-09-012026-09-22
Postpartum 8-aminoquinoline Breast Milk Study
Daily primaquine (0.5 mg/kg per day) for 14 days given with food food and water, Daily primaquine 1 mg/kg per day for 7 days given with food and water, Single-dose tafenoquine given with food and water to prevent gastrointestinal discomfort - Drug Pharmacokinetics in Healthy Volunteers
Phase 2 / Phase 3Not yet recruitingCurtin University602026-04-012026-03-18
Phase IIa/b Trial of PvCS/Montanide ISA-51 Malaria Vaccine in Adults in Chocó, Colombia
PvCS/Montanide ISA-51 VG Vaccine, Placebo - Montanide ISA-51 VG Adjuvant Alone - Plasmodium Vivax Malaria, Plasmodium Vivax Infection
Phase 2Not yet recruitingMalaria Vaccine and Drug Development Center722026-01-192026-01-28
Plasmodium Immunotherapy for Advanced Ovarian Cancer
Plasmodium immunotherapy - Advanced Ovarian Cancer
Phase 2 / Phase 3Not yet recruitingCAS Lamvac (Guangzhou) Biomedical Technology Co., Ltd.302024-07-202024-07-22
Primaquine Double Dose for Radical Cure of Plasmodium Vivax in Colombia
Primaquine double dose over 14 days, Primaquine single dose over 14 days - Malaria, Vivax, Relapse
Phase 2 / Phase 3WithdrawnUniversity of California, San Francisco2023-01-202023-05-11
Study to Evaluate Primaquine for Radical Cure of Uncomplicated Plasmodium Vivax Malaria in Children
Primaquine - Malaria, Vivax
Phase 2CompletedFundação de Medicina Tropical Dr. Heitor Vieira Dourado1002021-08-262025-02-20
Efficacy of a Synthetic Vaccine Derived From Plasmodium Vivax Circumsporozoite Protein (PvCS) in naïve and Semi-immune Volunteers
Vaccine PvCS N+C+R 150 mcg, Placebo SSN Montanide ISA-51 1 mL - Malaria, Vivax
Phase 2UnknownMalaria Vaccine and Drug Development Center1202021-06-012021-03-01
Efficacy of SJ733 in Adults With Uncomplicated Plasmodium Falciparum or Vivax Malaria
(+)-SJ000557733 (SJ733) - Malaria, Falciparum, Malaria, Vivax
Phase 2CompletedR. Kiplin Guy222021-04-142023-12-04
Safety, Immunogenicity and Efficacy of the Blood-stage Plasmodium Vivax Malaria Vaccine Candidate PvDBPII in Matrix M1
PvDBPII/Matrix-M1 - Malaria, Vivax
Phase 1 / Phase 2CompletedUniversity of Oxford242020-01-242024-11-25
VAC071: A Study to Assess Efficacy of the ChAd63/MVA PvDBP Vaccines
ChAd63 PvDBP and MVA PvDBP - Malaria, Vivax
Phase 2CompletedUniversity of Oxford162019-07-182024-04-12
Combination Momordica Charantia Extract and Primaquine Againts Plasmodium Falciparum Uncomplicated and Plasmodium Vivax Uncomplicated Treatment in Manokwari, West Papua
Dihydroartemisinin, Piperaquine, Primaquine - Malaria,Falciparum, Malaria, Vivax
Phase 2CompletedSyamsudin Abdillah,Ph.D, Pharm D502019-01-112023-09-13
Safety and Efficacy of Different Regimens of Primaquine on Vivax Malaria Treatment in G6PD Deficient Patients
Chloroquine, Primaquine - Vivax Malaria, G6PD Deficiency
Phase 2CompletedFundação de Medicina Tropical Dr. Heitor Vieira Dourado1062018-07-202025-02-20
A Pharmacokinetics, Safety and Efficacy Study of Tafenoquine (TQ) in Pediatric Subjects With Plasmodium Vivax (P. Vivax) Malaria
Tafenoquine, Chloroquine - Malaria, Vivax
Phase 2CompletedGlaxoSmithKline602017-02-062020-11-02
Plasmodium Immunotherapy for Lung Cancer
Blood-stage infection of P. vivax - Lung Cancer, Nonsmall Cell
Phase 1 / Phase 2UnknownState Key Laboratory of Respiratory Disease302016-06-272023-06-22
P.Vivax Treatment Trial
Dihydroartemisinin-piperaquine (DP) + Primaquine (PQ), Dihydroartemisinin-piperaquine (DP) + Primaquine (PQ) placebo - Plasmodium Vivax
Phase 1 / Phase 2CompletedUniversity of Oxford412016-06-142022-03-02
Methylene Blue Against Vivax Malaria in Ethiopia
Artemeter-Lumefantrine and MB (combination therapy), Artemeter-Lumefantrine (combination therapy), Artemeter-Lumefantrine and Primaquine (combination therapy) - Vivax Malaria
Phase 2WithdrawnHeidelberg University2016-04-012020-03-25
DSM265 Phase IIa Investigation Treating Plasmodium Falciparum or Vivax
DSM265 400mg, DSM265 xmg, DSM265 ymg - Plasmodium Falciparum Malaria, Plasmodium Vivax Malaria
Phase 2CompletedMedicines for Malaria Venture452016-01-012016-06-22
Efficacy of Chloroquine (CQ) Alone Compared to Concomitant CQ and Primaquine for Plasmodium Vivax Infection
Chloroquine, Primaquine - Malaria, Vivax
Phase 2 / Phase 3CompletedOswaldo Cruz Foundation2042014-08-012016-02-25

Showing 20 of 29. Sign in to see all of them.

Narrower conditions

Malaria (11)  ·  Malaria, Falciparum (4)  ·  Glucosephosphate Dehydrogenase Deficiency (2)  ·  Recurrence (2)  ·  Anemia (1)  ·  Breast Feeding (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Chills (1)  ·  Fever (1)  ·  Infections (1)  ·  Parasitemia (1)

Broader conditions

Mosquito-Borne Diseases (29)  ·  Parasitic Diseases (29)  ·  Protozoan Infections (29)  ·  Vector Borne Diseases (29)  ·  Infections (28)  ·  Malaria (18)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Pathologic Processes (3)  ·  Anemia (2)  ·  Anemia, Hemolytic (2)  ·  Anemia, Hemolytic, Congenital (2)  ·  Carbohydrate Metabolism, Inborn Errors (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)

Interventions

Primaquine (10)  ·  Chloroquine (9)  ·  tafenoquine (6)  ·  SJ733 (2)  ·  artenimol (2)  ·  piperaquine (2)  ·  3,7-bis(diethylamino)phenothiazin-5-ium (1)  ·  Combined Modality Therapy (1)  ·  DSM265 (1)  ·  Food (1)  ·  Matrix-M (1)  ·  Tinidazole (1)  ·  Water (1)  ·  artefenomel (1)  ·  bitter melon extract (1)

Sponsors

University of Oxford (4)  ·  Malaria Vaccine and Drug Development Center (3)  ·  Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (2)  ·  GlaxoSmithKline (2)  ·  Medicines for Malaria Venture (2)  ·  R. Kiplin Guy (2)  ·  U.S. Army Medical Research and Development Command (2)  ·  Alfasigma S.p.A. (1)  ·  CAS Lamvac (Guangzhou) Biomedical Technology Co., Ltd. (1)  ·  Curtin University (1)  ·  Heidelberg University (1)  ·  London School of Hygiene and Tropical Medicine (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Oswaldo Cruz Foundation (1)  ·  Socrates Herrera Valencia (1)

Countries

Colombia (5)  ·  Brazil (4)  ·  Peru (4)  ·  Thailand (4)  ·  China (2)  ·  United Kingdom (2)  ·  United States (2)  ·  Vietnam (2)  ·  Bangladesh (1)  ·  Cambodia (1)  ·  Ethiopia (1)  ·  France (1)  ·  Germany (1)  ·  India (1)  ·  Indonesia (1)

Top investigators

Alejandro L Cuentas, MD, PhD (1)  ·  Alejandro L Cuentas,, MD, PhD (1)  ·  Alejandro Llanos, Professor (1)  ·  Angela M Minassian, Dr (1)  ·  Angela M Minassian, MBBS MA DPhil MRCP FRCPath (1)  ·  Brioni Moore, PhD (1)  ·  Christoph Hatz, Prof Dr Med (1)  ·  Cindy Chu, MD, PhD (1)  ·  Francois Nosten, MD (1)  ·  Guo Shuiqun, Ph.D., M.D. (1)  ·  Jason Bennett, MD (1)  ·  Marcus VG Lacerda, MD, PhD (1)

Results publications

PMID 35664997, PMID 17707447, PMID 21292874, PMID 21931708, PMID 23718705, PMID 24088113, PMID 24360369, PMID 24963662, PMID 26248362, PMID 26448141, PMID 26500351, PMID 26654101, PMID 28318100, PMID 29121061, PMID 29909069, PMID 30269312, PMID 30650322, PMID 30782991, PMID 31888643, PMID 31900172, PMID 34161579, PMID 34871570, PMID 39785834, PMID 41430686

NIH funding

U01AI195203 (1)